• español
  • English
  • français
  • Deutsch
  • português (Brasil)
  • italiano
    • español
    • English
    • français
    • Deutsch
    • português (Brasil)
    • italiano
    • español
    • English
    • français
    • Deutsch
    • português (Brasil)
    • italiano
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Parcourir

    Tout UVaDOCCommunautésPar date de publicationAuteursSujetsTitres

    Mon compte

    Ouvrir une session

    Statistiques

    Statistiques d'usage de visualisation

    Compartir

    Voir le document 
    •   Accueil de UVaDOC
    • PUBLICATIONS SCIENTIFIQUES
    • Institutos de Investigación
    • Instituto de Biología y Genética Molecular (IBGM)
    • IBGM - Artículos de revista
    • Voir le document
    •   Accueil de UVaDOC
    • PUBLICATIONS SCIENTIFIQUES
    • Institutos de Investigación
    • Instituto de Biología y Genética Molecular (IBGM)
    • IBGM - Artículos de revista
    • Voir le document
    • español
    • English
    • français
    • Deutsch
    • português (Brasil)
    • italiano

    Exportar

    RISMendeleyRefworksZotero
    • edm
    • marc
    • xoai
    • qdc
    • ore
    • ese
    • dim
    • uketd_dc
    • oai_dc
    • etdms
    • rdf
    • mods
    • mets
    • didl
    • premis

    Citas

    Por favor, use este identificador para citar o enlazar este ítem:https://uvadoc.uva.es/handle/10324/47502

    Título
    Study of the true clinical progression of autosomal dominant alport syndrome in a european population
    Autor
    Rosado, Consolación
    Bueno Martínez, ElenaAutoridad UVA Orcid
    Felipe, Carmen
    Valverde, Sebastián
    González Sarmiento, Rogelio
    Año del Documento
    2015
    Editorial
    Karger Publishers
    Descripción
    Producción Científica
    Documento Fuente
    Kidney and Blood Pressure Research, 2015, vol. 40, n. 4, p. 435-442
    Résumé
    Background/Aims:Autosomal dominant Alport syndrome represents 5% of all Alport syndrome cases. This entity presents a different clinical expression from the recessive inheritance pattern and the X chromosome-linked pattern, because it is mild and it shows a late onset, which in many cases even goes unnoticed. Methods:We carried out a descriptive observational and retrospective clinical study on 19 patients from 5 families with a clinical diagnosis of autosomal dominant Alport Syndrome, and we analyzed the expression of the symptoms in the different families, comparing the results with what has been described in the literature. Results:Renal involvement appeared at a young age, with a progression towards end-stage chronic kidney disease at a median age of 31 years (20.5-36.5). Hearing involvement also appeared in early stages, at a median age of 28.5 years (7.5-62.5). Also, we observed ocular lenticonus-like injuries, which until now have only been described in other inheritance patterns. Conclusions:Our results suggest that dominant patterns are accompanied by a severe clinical expression that can be superimposed to the recessive and X chromosome-linked patterns, contrary to what has been classically stated. The high phenotypic variability observed in the families lead to the fact that many cases go unnoticed and the severest cases are erroneously diagnosed as recessive, which means that the real prevalence of dominant forms is probably higher than the current 5%.
    Materias Unesco
    24 Ciencias de la Vida
    Palabras Clave
    Alport syndrome
    COL4A3
    COL4A4
    Autosomal dominant inheritance
    ISSN
    1420-4096
    Revisión por pares
    SI
    DOI
    10.1159/000368519
    Version del Editor
    https://www.karger.com/Article/FullText/368519
    Propietario de los Derechos
    © 2015 S. Karger AG
    Idioma
    eng
    URI
    https://uvadoc.uva.es/handle/10324/47502
    Tipo de versión
    info:eu-repo/semantics/publishedVersion
    Derechos
    openAccess
    Aparece en las colecciones
    • IBGM - Artículos de revista [78]
    Afficher la notice complète
    Fichier(s) constituant ce document
    Nombre:
    Study-true-clinical-progression.pdf
    Tamaño:
    891.9Ko
    Formato:
    Adobe PDF
    Thumbnail
    Voir/Ouvrir
    Attribution-NonCommercial-NoDerivatives 4.0 InternacionalExcepté là où spécifié autrement, la license de ce document est décrite en tant que Attribution-NonCommercial-NoDerivatives 4.0 Internacional

    Universidad de Valladolid

    Powered by MIT's. DSpace software, Version 5.10